New funding for breakthrough direct-to-consumer DNA technology and services
LOS ANGELES, November 8, 2022 /PRNewswire-PRWeb/ — Sequencing.com, the leader in direct-to-consumer DNA interpretation, has increased 5 million dollars in venture capital financing. The funding is led by Lerer Hippeau and includes Red Sea Ventures, Global Founders Capital, XRC Labs, Correlation Ventures, Red Antler, Mucker Capital and Gaingels.
“Within the next 5 years we expect that between 100 million and 2 billion human genomes will be sequenced. This fundraising allows us to rapidly expand our unique solutions that unlock the true value of genetic data and directly empower individuals,” said Dr. Brandon Colby, Chief Executive Officer and Founder of Sequencing.com. “We are thrilled to partner with proven consumer-centric investors who support our broader mission of empowering everyone to trick their genes.”
Based on the latest DNA technology
The new round of funding will allow Sequencing.com to continue to grow and enhance its DNA technology, which includes adding a 30X whole genome sequencing service with the fastest direct-to-consumer turnaround time. In addition, the company offers the world’s largest marketplace for DNA analyzes and reports with over 100 apps and counting.
“Sequencing.com’s offering makes whole genome analysis accessible and affordable for the first time,” he said Caitlin Strandberg, Partner at Lerer Hippeau. “This…
